sofosbuvir has been researched along with camostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boccuto, A; Crespan, E; De Angelis, M; Decroly, E; Dragoni, F; Eydoux, C; Giavarini, G; Maga, G; Marchi, S; Martina, MG; Montomoli, E; Nencioni, L; Radi, M; Trombetta, CM; Vicenti, I; Zazzi, M | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for sofosbuvir and camostat
| Article | Year |
|---|---|
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2.
Topics: Antiviral Agents; Flavivirus; Molecular Targeted Therapy; Orthomyxoviridae; Purines; SARS-CoV-2; Virus Replication | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |